Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.850
-0.020 (-1.07%)
At close: Sep 30, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
Pre-market: Oct 1, 2026, 4:00 AM EDT
Alector Market Cap
Alector has a market cap or net worth of $206.57 million as of September 30, 2026. Its market cap has decreased by -33.08% in one year.
Market Cap
206.57M
Enterprise Value
66.53M
1-Year Change
-33.08%
Ranking
Category
Stock Price
$1.85
ChartMarket Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $206.57M, a decrease of -83.21%. That is a compound annual growth rate of -20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 206.57M | 21.31% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 222.60M |
| Keros Therapeutics | 221.87M |
| Cartesian Therapeutics | 219.05M |
| Anavex Life Sciences | 218.76M |
| Protalix BioTherapeutics | 216.74M |
| Adagene | 215.53M |
| Whitehawk Therapeutics | 212.64M |
| Foghorn Therapeutics | 209.04M |